Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
3.85M
-
Shares change
-
-175K
-
Total reported value, excl. options
-
$11.4M
-
Value change
-
-$517K
-
Number of buys
-
6
-
Number of sells
-
-7
-
Price
-
$2.95
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q4 2020
24 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q4 2020.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.85M shares
of 15M outstanding shares and own 25.75% of the company stock.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (821K shares), DIMENSIONAL FUND ADVISORS LP (782K shares), RENAISSANCE TECHNOLOGIES LLC (675K shares), VANGUARD GROUP INC (392K shares), BlackRock Inc. (362K shares), Stonepine Capital Management, LLC (189K shares), BERKSHIRE ASSET MANAGEMENT LLC/PA (165K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (151K shares), ACADIAN ASSET MANAGEMENT LLC (105K shares), and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (53.4K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.